Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification
International Journal of Pharma Medicine and Biological Sciences · 01.01.2026 · 34
DOI: 10.18178/ijpmbs.15.2.34-37 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharma Medicine and Biological Sciences, online erschienen am 01.01.2026. Verfasst von Yifan Li.
Abstract (Originalsprache)
Chimeric Antigen Receptor (CAR)-T cell therapy has achieved remarkable success in the treatment of hematological malignancies, but its efficacy in solid tumors is still severely limited by T cell exhaustion.As one of the core regulators of T cell exhaustion, Programmed Cell Death Protein 1 (PD-1) plays a key role in this process.However, current targeting strategies for PD-1 still have inherent limitations, making it difficult to strike a balance between effective anti-tumor and maintenance of immune homeostasis.This article proposes a new regulatory strategy that uses PRIME editing technology to precisely modify the PD-1 promoter.As a new generation of gene editing tools, PRIME can achieve precise replacement at the single nucleotide level without inducing DNA double-strand breaks.By precisely modifying key regulatory elements in the PD-1 promoter region, this strategy can moderately downregulate PD-1 expression and effectively alleviate T cell exhaustion while retaining partial PD-1 function to maintain immune homeostasis.This regulatory idea provides a new technical path and theoretical support for the future construction of universal CAR-T cells with low exhaustion and high persistence.
Zitieren
APA
Li, Y. (2026). Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification. International Journal of Pharma Medicine and Biological Sciences, 34. https://doi.org/10.18178/ijpmbs.15.2.34-37
Vancouver
Li Y. Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification. International Journal of Pharma Medicine and Biological Sciences. 2026:34. doi:10.18178/ijpmbs.15.2.34-37
BibTeX
@article{Li2026,
author = {Li, Yifan},
title = {Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification},
journal = {International Journal of Pharma Medicine and Biological Sciences},
year = {2026},
pages = {34},
doi = {10.18178/ijpmbs.15.2.34-37}
}
EUVIMED